IL-33-Pretreated Mesenchymal Stem Cells Attenuate Acute Liver Failure by Improving Homing and Polarizing M2 Macrophages

• Váldodahkkit: Hui Yuan (Dahkki), Yuwen Li (Dahkki), Zihao Kong (Dahkki), Linya Peng (Dahkki), Jiali Song (Dahkki), Xiaoxue Hou (Dahkki), Wen Zhang (Dahkki), Rui Liu (Dahkki), Tiantong Feng (Dahkki), Chuanlong Zhu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi Limited, 2024-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Mesenchymal stem cells (MSCs) are highly effective in the treatment of acute liver failure (ALF). The efficacy of MSCs is closely related to the inflammatory environment. Therefore, we investigated the functional changes of MSCs in response to interleukin-33 (IL-33) stimulation. The results showed t...